Literature DB >> 15015183

Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature.

P Klinkert1, P N Post, P J Breslau, J H van Bockel.   

Abstract

The autogenous saphenous vein is considered the best bypass graft material for arterial bypasses below the inguinal ligament. However, a synthetic graft or prosthesis is considered an acceptable alternative, especially when the distal anastomosis is situated above the knee. Some studies even suggest that patency rates for vein and synthetic grafts are comparable, whereas others indicate that a vein graft is superior to a prosthetic graft, even above the knee. To test the hypothesis that both vein grafts and synthetic prostheses are equally beneficial in the above-knee position, we performed a systematic review of available studies comparing the patency of saphenous vein and polytetrafluoroethylene (PTFE) as bypass material. English and German medical literature from 1966 to 2002 was searched using Medline, and 25 articles meeting our inclusion and exclusion criteria were selected. The patency of venous bypasses was superior to that of PTFE bypasses at all time intervals studied. After 2 years, the primary patency rate of venous bypasses was 81% as compared to 67% for PTFE bypasses, and after 5 years it was 69 and 49%, respectively. After 5 years, the secondary patency of PTFE bypasses reached 60%. When only randomized trials were considered, venous bypasses were again superior to PTFE bypasses at all intervals studied. After 2 years, the primary patency rate of venous and PTFE bypasses was 80 and 69%, respectively, and after 5 years it was 74 and 39%, respectively. Since both randomized and retrospective studies comparing venous with PTFE bypasses showed that vein grafts were 'better' than PTFE prostheses, the null hypothesis that there is no difference between the two types of graft material was rejected (p=0.008). We conclude from this systematic review that if a saphenous vein is available, a venous bypass should be chosen at all times, even if patients have an anticipated short life expectancy (<2 years). If the saphenous vein is absent or not suitable for bypass grafting, PTFE is a good alternative as bypass material.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015183     DOI: 10.1016/j.ejvs.2003.12.027

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  88 in total

1.  Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection infusion for chronic lower extremity ischemia: 3-year results.

Authors:  Hai Feng; Xue-ming Chen; Chen-yu Li; Ren-ming Zhu; Jie Fang; Tian-you Wang
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

2.  Effect of fibroin sponge coating on in vivo performance of knitted silk small diameter vascular grafts.

Authors:  Toshiharu Fukayama; Yusuke Ozai; Haruka Shimokawadoko; Derya Aytemiz; Ryou Tanaka; Noboru Machida; Tetsuo Asakura
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

Review 3.  Endothelial progenitor cell-seeded grafts: rash and risky.

Authors:  Joris I Rotmans; Jan M M Heyligers; Erik S G Stroes; Gerard Pasterkamp
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 4.  Endothelial progenitor cell-seeded grafts: rash and risky.

Authors:  Joris I Rotmans; Jan M M Heyligers; Erik S G Stroes; Gerard Pasterkamp
Journal:  Can J Cardiol       Date:  2006-11       Impact factor: 5.223

Review 5.  Development of small-diameter vascular grafts.

Authors:  Xinwen Wang; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

6.  Cuffed anastomosis for above-knee femoropopliteal bypass with a stretch expanded polytetrafluoroethylene graft.

Authors:  Yoshinori Inoue; Norihide Sugano; Masatoshi Jibiki; Siro Kitamura; Takehisa Iwai
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

7.  Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.

Authors:  Klaus Kallenbach; Rolf Salcher; Albert Heim; Matthias Karck; Paolo Mignatti; Axel Haverich
Journal:  J Vasc Surg       Date:  2009-03       Impact factor: 4.268

Review 8.  Endothelial outgrowth cells: function and performance in vascular grafts.

Authors:  Jeremy J Glynn; Monica T Hinds
Journal:  Tissue Eng Part B Rev       Date:  2013-10-10       Impact factor: 6.389

9.  The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models.

Authors:  Timothy Pennel; George Fercana; Deon Bezuidenhout; Agneta Simionescu; Ting-Hsien Chuang; Peter Zilla; Dan Simionescu
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

10.  Promoting Endothelial Cell Affinity and Antithrombogenicity of Polytetrafluoroethylene (PTFE) by Mussel-Inspired Modification and RGD/Heparin Grafting.

Authors:  Hao-Yang Mi; Xin Jing; James A Thomsom; Lih-Sheng Turng
Journal:  J Mater Chem B       Date:  2018-05-09       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.